Related Experiment Video
Updated: May 15, 2026

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
Published on: January 7, 2019
Molecular genetics of charcot-marie-tooth disease: from genes to genomes
H Azzedine1, J Senderek, C Rivolta
1Department of Medical Genetics, University of Lausanne, Lausanne, Switzerland.
Abstract:
Charcot-Marie-Tooth disease (CMT) is a heterogeneous group of disorders of the peripheral nervous system, mainly characterized by distal muscle weakness and atrophy leading to motor handicap. With an estimated prevalence of 1 in 2,500, this condition is one of the most commonly inherited neurological disorders. Mutations in more than 30 genes affecting glial and/or neuronal functions have been associated with different forms of CMT leading to a substantial improvement in diagnostics of the disease and in the understanding of implicated pathophysiological mechanisms. However, recent data from systematic genetic screening performed in large cohorts of CMT patients indicated that molecular diagnosis could be established only in ∼50-70% of them, suggesting that additional genes are involved in this disease. In addition to providing an overview of genetic and functional data concerning various CMT forms, this review focuses on recent data generated through the use of highly parallel genetic technologies (SNP chips, sequence capture and next-generation DNA sequencing) in CMT families, and the current and future impact of these technologies on gene discovery and diagnostics of CMTs.
Insights
Charcot-Marie-Tooth disease (CMT) is a common inherited neurological disorder. Advanced genetic technologies are improving diagnosis and discovering new genes for CMT, aiding understanding of its mechanisms.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Charcot-Marie-Tooth disease (CMT) is a prevalent inherited peripheral nervous system disorder causing muscle weakness and atrophy.
- Over 30 genes are linked to CMT, significantly advancing diagnostics and understanding of disease mechanisms.
- Despite advances, molecular diagnosis remains elusive in 30-50% of CMT patients, indicating undiscovered genetic factors.
Purpose of the Study:
- To review genetic and functional data for various CMT forms.
- To highlight recent advancements in gene discovery for CMT using high-throughput genetic technologies.
- To discuss the impact of these technologies on CMT diagnosis and research.
Main Methods:
- Review of genetic and functional data from CMT research.
- Analysis of data from systematic genetic screening in large CMT patient cohorts.
- Focus on findings from SNP chips, sequence capture, and next-generation DNA sequencing in CMT families.
Main Results:
- Current genetic screening identifies causative mutations in only 50-70% of CMT cases.
- Highly parallel genetic technologies are instrumental in identifying novel CMT-associated genes.
- These technologies are enhancing the diagnostic yield and understanding of CMT pathophysiology.
Conclusions:
- Additional genes beyond the known 30+ are implicated in Charcot-Marie-Tooth disease.
- Next-generation sequencing and related technologies are crucial for future CMT gene discovery.
- These advancements will significantly improve molecular diagnostics and therapeutic strategies for CMT.
More Related Videos
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
06:35In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
Related Concept Videos
Incomplete Dominance
Animal Mitochondrial Genetics
Pharmacogenomics: Identification of New Drug Targets
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Genomics